These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34371283)

  • 1. Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration.
    Long Z; Irish M; Hodges JR; Halliday G; Piguet O; Burrell JR
    Neurobiol Aging; 2021 Nov; 107():11-20. PubMed ID: 34371283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis.
    Irwin DJ; McMillan CT; Brettschneider J; Libon DJ; Powers J; Rascovsky K; Toledo JB; Boller A; Bekisz J; Chandrasekaran K; Wood EM; Shaw LM; Woo JH; Cook PA; Wolk DA; Arnold SE; Van Deerlin VM; McCluskey LF; Elman L; Lee VM; Trojanowski JQ; Grossman M
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):163-9. PubMed ID: 23117491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
    Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frontotemporal syndromes of ALS. Clinicopathological correlates.
    Strong MJ; Yang W
    J Mol Neurosci; 2011 Nov; 45(3):648-55. PubMed ID: 21809041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.
    Cousins KAQ; Shaw LM; Chen-Plotkin A; Wolk DA; Van Deerlin VM; Lee EB; McMillan CT; Grossman M; Irwin DJ
    JAMA Neurol; 2022 Nov; 79(11):1155-1164. PubMed ID: 36215050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP.
    Olm CA; Burke SE; Peterson C; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M; Gee JC
    Neuroimage Clin; 2023; 37():103285. PubMed ID: 36508888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
    Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
    Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.
    McMillan CT; Irwin DJ; Avants BB; Powers J; Cook PA; Toledo JB; McCarty Wood E; Van Deerlin VM; Lee VM; Trojanowski JQ; Grossman M
    J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):949-55. PubMed ID: 23475817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.
    Woodworth DC; Nguyen KM; Sordo L; Scambray KA; Head E; Kawas CH; Corrada MM; Nelson PT; Sajjadi SA
    Acta Neuropathol; 2024 Jun; 147(1):103. PubMed ID: 38896163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology.
    Burke SE; Phillips JS; Olm CA; Peterson CS; Cook PA; Gee JC; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M
    Neurobiol Aging; 2022 May; 113():95-107. PubMed ID: 35325815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
    Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
    Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes.
    Pasquini L; Pereira FL; Seddighi S; Zeng Y; Wei Y; Illán-Gala I; Vatsavayai SC; Friedberg A; Lee AJ; Brown JA; Spina S; Grinberg LT; Sirkis DW; Bonham LW; Yokoyama JS; Boxer AL; Kramer JH; Rosen HJ; Humphrey J; Gitler AD; Miller BL; Pollard KS; Ward ME; Seeley WW
    Brain; 2024 Sep; 147(9):3032-3047. PubMed ID: 38940350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.